St. Louis Financial Planners Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
St. Louis Financial Planners Asset Management's BMY Position: Q3 2023 in Review
St. Louis Financial Planners Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 27,134 shares — an estimated $1.74M sold.
St. Louis Financial Planners Asset Management first reported a position in BMY in Q1 2023 and held it in 2 quarters. The position peaked at $1.74M in Q2 2023. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.
- St. Louis Financial Planners Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
- St. Louis Financial Planners Asset Management sold 27,134 Bristol-Myers Squibb shares in Q3 2023, an estimated $1.74M.
- St. Louis Financial Planners Asset Management first reported a position in Bristol-Myers Squibb in Q1 2023 and held it in 2 quarters.
- St. Louis Financial Planners Asset Management's Bristol-Myers Squibb position peaked at $1.74M in Q2 2023.
- 2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.
Based on St. Louis Financial Planners Asset Management's 13F filing for Q3 2023, filed 6 Oct 2023.